Mezzano S, Burgos E, Mahabir R, Kemeny E, Zabriskie J B
Division of Nephrology, Universidad Austral, Valdivia, Chile.
Clin Nephrol. 1992 Dec;38(6):305-10.
Using purified group A streptokinase (SKA) as the antigen, ELISA assays were carried out on the sera of normal unaffected children, acute poststreptococcal glomerulonephritis patients (APSGN) and acute rheumatic fever patients (ARF). The results demonstrate that antibody titers to SKA increase with age in normal children and by age 8 years the vast majority of children have antibodies to SKA. APSGN patients did not demonstrate unique reactivity to SKA when compared to ARF patients either at time of onset of disease or during convalescence. Polyclonal and monoclonal antibodies to SKA which recognize both group A and C streptokinase failed to detect the presence of streptokinase in the biopsy sections obtained from ten well-documented APSGN patients. We conclude that there is no unique reactivity to group A streptokinase in the sera of APSGN patients. Furthermore, we failed to demonstrate the presence of streptokinase in the biopsy specimens of an early case of APSGN patients.
以纯化的A组链球菌激酶(SKA)作为抗原,对正常未患病儿童、急性链球菌感染后肾小球肾炎患者(APSGN)和急性风湿热患者(ARF)的血清进行酶联免疫吸附测定(ELISA)。结果表明,正常儿童中针对SKA的抗体滴度随年龄增长而升高,到8岁时绝大多数儿童都有针对SKA的抗体。与ARF患者相比,APSGN患者在疾病发作时或恢复期对SKA均未表现出独特的反应性。识别A组和C组链球菌激酶的抗SKA多克隆抗体和单克隆抗体未能在取自10例记录完整的APSGN患者的活检切片中检测到链球菌激酶的存在。我们得出结论,APSGN患者血清中对A组链球菌激酶没有独特的反应性。此外,我们未能在一例早期APSGN患者的活检标本中证明链球菌激酶的存在。